Despite receiving biologics, IBD patients develop antibodies after COVID-19 vaccines

Despite receiving biologics, IBD patients develop antibodies after COVID-19 vaccines

Serological responses from patients with inflammatory bowel disease on biologic therapies had 100% seropositivity after two doses of the COVID-19 mRNA vaccinations, according to a study published in Gastroenterology.“Based upon recent studies of antibodies in patients who have had COVID-19 or just one of two vaccine doses, concerns have been raised whether IBD patients receiving biological therapies can mount immune responses to COVID-19 vaccination,” lead author, Serre-Yu Wong, MD, PhD, instructor, division of gastroenterology, Icahn School of Medicine at Mount Sinai, told HealioRead More

Share on facebook
Share on twitter
Share on linkedin